Cargando…
Complement C3: an emerging risk factor in cardiometabolic disease
C3 is the central component of the complement system and activation of C3 via any of the three major activation pathways—the classical, the lectin and the alternative pathways—results in initiation of the terminal complement pathway and release of the anaphylatoxin C3a. Both terminal pathway activat...
Autores principales: | Hertle, E., van Greevenbroek, M. M. J., Stehouwer, C. D. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3295998/ https://www.ncbi.nlm.nih.gov/pubmed/22282163 http://dx.doi.org/10.1007/s00125-012-2462-z |
Ejemplares similares
-
Complement C3 and C4, but not their regulators or activated products, are associated with incident metabolic syndrome: the CODAM study
por: Xin, Ying, et al.
Publicado: (2018) -
Associations of dicarbonyl stress with complement activation: the CODAM study
por: Xin, Ying, et al.
Publicado: (2020) -
Why would associations between cardiometabolic risk factors and depressive symptoms be linear?
por: de Jonge, Peter, et al.
Publicado: (2014) -
Complement component 3 as biomarker of disease activity and
cardiometabolic risk factor in rheumatoid arthritis and
spondyloarthritis
por: Arias de la Rosa, Iván, et al.
Publicado: (2020) -
A randomized diet‐induced weight‐loss intervention reduces plasma complement C3: Possible implication for endothelial dysfunction
por: Jin, Shunxin, et al.
Publicado: (2022)